Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cardiovascular Systems (CSII) Short Interest Ratio & Short Volume

Cardiovascular Systems logo

Cardiovascular Systems Short Interest Data

Cardiovascular Systems (CSII) has a short interest of 1.74 million shares. This marks a 48.72% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 765,906 shares to cover all short positions.

Current Short Interest
1,740,000 shares
Previous Short Interest
1,170,000 shares
Change Vs. Previous Month
+48.72%
Dollar Volume Sold Short
$34.75 million
Short Interest Ratio
2.0 Days to Cover
Last Record Date
April 15, 2023
Outstanding Shares
42,198,000 shares
Percentage of Shares Shorted
4.12%
Today's Trading Volume
4,300 shares
Average Trading Volume
765,906 shares
Today's Volume Vs. Average
1%
Short Selling Cardiovascular Systems?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cardiovascular Systems and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CSII Short Interest Over Time

CSII Days to Cover Over Time

CSII Percentage of Float Shorted Over Time

Cardiovascular Systems Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20231,740,000 shares $34.75 million +48.7%N/A2 $19.97
3/31/20231,170,000 shares $23.24 million -35.4%2.9%1.4 $19.86
3/15/20231,810,000 shares $35.77 million +30.2%4.5%2.3 $19.76
2/28/20231,390,000 shares $27.40 million +25.2%3.5%2.1 $19.71
2/15/20231,110,000 shares $21.87 million -24.0%2.8%1.8 $19.70
1/31/20231,460,000 shares $20.35 million +1.4%3.7%3.2 $13.94
1/15/20231,440,000 shares $20.16 million No Change3.6%5.3 $14.00
12/30/20221,440,000 shares $19.61 million +7.5%3.6%5.2 $13.62
12/15/20221,340,000 shares $19.10 million +7.2%3.4%4.8 $14.25
11/30/20221,250,000 shares $17.51 million -1.6%3.1%4.7 $14.01
11/15/20221,270,000 shares $18.71 million -18.6%N/A4.6 $14.73
10/31/20221,560,000 shares $22.53 million +6.9%N/A5.9 $14.44
10/15/20221,460,000 shares $18.92 million +2.8%3.7%5.5 $12.96
9/30/20221,420,000 shares $19.68 million No Change3.6%5.5 $13.86
9/15/20221,420,000 shares $20.14 million +0.7%3.6%5.2 $14.18
8/31/20221,410,000 shares $18.63 million +7.6%3.6%4.8 $13.21
8/15/20221,310,000 shares $22.49 million -9.7%3.9%4.4 $17.17
7/31/20221,450,000 shares $22.34 million +17.9%4.3%4.2 $15.41
7/15/20221,230,000 shares $18.67 million +3.4%3.7%3.6 $15.18
6/30/20221,190,000 shares $17.09 million -17.9%3.6%3.4 $14.36
6/15/20221,450,000 shares $20.78 million +4.3%4.3%4.2 $14.33
5/31/20221,390,000 shares $22.60 million +0.7%3.5%4.4 $16.26
5/15/20221,380,000 shares $22.00 million +5.3%3.5%4 $15.94
4/30/20221,310,000 shares $24.50 million -1.5%3.3%3.7 $18.70
4/15/20221,330,000 shares $28.63 million -16.4%3.4%3.6 $21.53
3/31/20221,590,000 shares $35.93 million -10.2%4.1%3.8 $22.60
3/15/20221,770,000 shares $34.46 million -7.8%4.5%3.9 $19.47
2/28/20221,920,000 shares $40.44 million +3.2%4.9%3.9 $21.06
2/15/20221,860,000 shares $36.46 million -12.3%4.7%3.6 $19.60
1/31/20222,120,000 shares $37.25 million +27.7%5.4%4.1 $17.57
1/15/20221,660,000 shares $31.84 million +10.7%4.2%3.7 $19.18
12/31/20211,500,000 shares $28.17 million +72.2%3.8%3.9 $18.78
12/15/2021870,900 shares $17.10 million -12.5%2.2%2.4 $19.63
11/30/2021995,200 shares $19.90 million +2.9%2.5%3.4 $20.00
11/15/2021967,500 shares $25.06 million -14.4%2.5%4 $25.90
10/29/20211,130,000 shares $39.64 million -5.8%2.9%5.8 $35.08
10/15/20211,200,000 shares $40.22 million +5.3%3.1%6.1 $33.52
9/30/20211,140,000 shares $37.43 million -19.7%2.9%4.9 $32.83
9/15/20211,420,000 shares $50.86 million -9.6%3.7%6.3 $35.82
8/31/20211,570,000 shares $56.19 million -9.3%4.0%7.3 $35.79
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
8/13/20211,730,000 shares $62.40 million +11.6%4.5%7.9 $36.07
7/30/20211,550,000 shares $62.45 million +16.5%4.0%6.6 $40.29
7/15/20211,330,000 shares $47.88 million +18.8%3.4%6.1 $36.00
6/30/20211,120,000 shares $47.77 million -8.2%2.9%5.7 $42.65
6/15/20211,220,000 shares $48.86 million +5.2%3.1%6.3 $40.05
5/28/20211,160,000 shares $45.46 million +2.7%3.0%5.8 $39.19
5/14/20211,130,000 shares $40.27 million -0.9%N/A5.8 $35.64
4/30/20211,140,000 shares $46.38 million No ChangeN/A6 $40.68
4/15/20211,140,000 shares $43.24 million +0.9%N/A5.6 $37.93
3/31/20211,130,000 shares $42.14 million -8.1%N/A5.4 $37.29
3/15/20211,230,000 shares $51.56 million -7.5%N/A5.2 $41.92
2/26/20211,330,000 shares $55.02 million -7.6%N/A5.3 $41.37
2/12/20211,440,000 shares $62.21 million +15.2%N/A5.4 $43.20
1/29/20211,250,000 shares $57.40 million -0.8%N/A4.3 $45.92
1/15/20211,260,000 shares $57.53 million +0.8%N/A4.5 $45.66
12/31/20201,250,000 shares $54.71 million -10.7%N/A4.5 $43.77
12/15/20201,400,000 shares $52.74 million +41.2%N/A4.8 $37.67
11/30/2020991,400 shares $35.09 million +10.7%N/A3.1 $35.39
11/15/2020895,700 shares $32.50 million -8.8%N/A2.7 $36.29
10/30/2020982,200 shares $35.52 million -9.1%N/A3 $36.16
10/15/20201,080,000 shares $39.71 million -26.0%N/A3.3 $36.77
9/30/20201,460,000 shares $57.45 million +10.6%N/A4.1 $39.35
9/15/20201,320,000 shares $45.84 million -2.2%N/A3.7 $34.73
8/31/20201,350,000 shares $44.10 million +13.5%N/A3.5 $32.67
8/14/20201,190,000 shares $37.58 million -2.5%N/A3.3 $31.58
7/31/20201,220,000 shares $37.19 million +7.0%N/A3.4 $30.48
7/15/20201,140,000 shares $31.76 million -11.6%N/A3.2 $27.86
6/30/20201,290,000 shares $39.98 million +20.6%N/A3.9 $30.99
6/15/20201,070,000 shares $34.96 million -5.3%N/A3.3 $32.67
5/29/20201,130,000 shares $44.40 million -11.7%3.3%3.9 $39.29
5/15/20201,280,000 shares $44.48 million -16.9%3.8%4.1 $34.75

CSII Short Interest - Frequently Asked Questions

What is Cardiovascular Systems' current short interest?

Short interest is the volume of Cardiovascular Systems shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,740,000 shares of CSII short. Learn More on Cardiovascular Systems' current short interest.

What is a good short interest ratio for Cardiovascular Systems?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSII shares currently have a short interest ratio of 2.0. Learn More on Cardiovascular Systems's short interest ratio.

Is Cardiovascular Systems' short interest increasing or decreasing?

Cardiovascular Systems saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,740,000 shares, an increase of 48.7% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cardiovascular Systems' short interest compare to its competitors?

Here is how the short interest of companies compare to Cardiovascular Systems: AtriCure, Inc. (2.83%), Alphatec Holdings, Inc. (12.05%), Integra LifeSciences Holdings Co. (5.23%), Orthofix Medical Inc. (2.12%), Surmodics, Inc. (3.37%), AngioDynamics, Inc. (4.44%), Accuray Incorporated (4.01%), Rockwell Medical, Inc. (1.21%), ReShape Lifesciences Inc. (11.26%), Abbott Laboratories (1.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.69 billion), Occidental Petroleum Co. ($3.22 billion), Coinbase Global, Inc. ($2.54 billion), T. Rowe Price Group, Inc. ($2.33 billion), Paramount Global ($2.10 billion), Verisk Analytics, Inc. ($2.03 billion), Etsy, Inc. ($1.67 billion), Old Dominion Freight Line, Inc. ($1.62 billion), CarMax, Inc. ($1.60 billion), and Extra Space Storage Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Cardiovascular Systems stock?

Short selling CSII is an investing strategy that aims to generate trading profit from Cardiovascular Systems as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cardiovascular Systems?

A short squeeze for Cardiovascular Systems occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CSII, which in turn drives the price of the stock up even further.

How often is Cardiovascular Systems' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSII, twice per month. The most recent reporting period available is April, 15 2023.




This page (NASDAQ:CSII) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners